Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation
- 1 July 2006
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 148 (5) , 629-639
Abstract
The aim of this study was to assess the effects of treatment with isoproterenol (ISO, 0.3 mg kg−1 day−1, s.c.) for 7 days on the vascular reactivity of rat‐isolated aortic rings. Additionally, potential mechanisms underlying the changes that involved the endothelial modulation of contractility were investigated. Treatment with ISO induced cardiac hypertrophy without changes in haemodynamic parameters. Aortic rings from ISO‐treated rats showed an increase in the contraction response to phenylephrine (PHE) and serotonin, but did not change relaxations produced by acetylcholine or isoproterenol. Removal of the endothelium increased the responses to PHE in both groups. However, this procedure was less effective in ISO‐treated as compared with control rats. Endothelial cell removal abolished the increase in the response to PHE in ISO‐treated rats. The presence of Nω‐nitro‐L‐arginine methyl ester shifted the concentration–response curve to PHE to the left in both groups of rats. However, this effect was more pronounced in the ISO group. In addition, aminoguanidine (50 μM) potentiated the actions of PHE only in the ISO group. ISO treatment increased nitric oxide synthase (NOS) activity and neuronal NOS and endothelial NOS protein expression in the aorta. Neither losartan (10 μM) nor indomethacin (10 μM) abolished the effects of ISO on the actions of PHE. Superoxide dismutase (SOD, 150 U ml−1) and L‐arginine (5 mM), but neither catalase (300 U ml−1) nor apocynin (100 μM), blocked the effect of ISO treatment. In addition, we observed an increase in superoxide anion levels as measured by ethidium bromide fluorescence and of copper and zinc superoxide dismutase protein expression in ISO‐treated rats. In conclusion, our data suggest that ISO treatment alters the endothelial cell‐mediated modulation of the contraction to PHE in rat aorta. The increased maximal response of PHE seems to be due to an increase in superoxide anion generation, which inactivates some of the basal NO produced and counteracts NO‐mediated negative modulation even in the presence of high NO production and antioxidant defence. British Journal of Pharmacology (2006) 148, 629–639. doi:10.1038/sj.bjp.0706749Keywords
This publication has 42 references indexed in Scilit:
- Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteriesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- β-Adrenergic Activation Initiates Chamber Dilatation in Concentric HypertrophyHypertension, 2003
- Activation of nitric oxide synthase by β2‐adrenoceptors in human umbilical vein endothelium in vitroBritish Journal of Pharmacology, 1999
- Interaction between superoxide anion and nitric oxide in the regulation of vascular endothelial functionBritish Journal of Pharmacology, 1998
- The Cardiac β-Adrenoceptor–Mediated Signaling Pathway and Its Alterations in Hypertensive Heart DiseaseHypertension, 1997
- Down-regulation of β-adrenoceptors and loss of Gsα subunit levels in ventricular myocardium of rats treated with isoproterenolLife Sciences, 1993
- Selective Down Regulation of Vascular β1 Adrenergic Receptors After Prolonged Isoproterenol InfusionJournal of Cardiovascular Pharmacology, 1987
- Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factorNature, 1986
- Development of isoproterenol-indueed cardiac hypertrophyCanadian Journal of Physiology and Pharmacology, 1984
- Effects of In Vivo β-Adrenoceptor Down-Regulation on Cardiac Responses to Prenalterol and PirbuterolJournal of Cardiovascular Pharmacology, 1983